Brand New Modular Bioprocessing Facility From Novartis

Event | February 17, 2016 | Charleston, SC

Flexible multi-product facility for commercial manufacturing of recombinant protein products produced by microbial fermentation. The facility is designed for a single production line with one 2’000 L gross volume microbial production fermenter, equipped completely with the respective seed train and purification. Offers due by February 17, 2016.
Click here for additional information.